BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 36912663)

  • 1.
    Scott J; Valero C; Mato-López Á; Donaldson IJ; Roldán A; Chown H; Van Rhijn N; Lobo-Vega R; Gago S; Furukawa T; Morogovsky A; Ben Ami R; Bowyer P; Osherov N; Fontaine T; Goldman GH; Mellado E; Bromley M; Amich J
    Microbiol Spectr; 2023 Mar; 11(2):e0477022. PubMed ID: 36912663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Efficacy of Voriconazole in a
    Jemel S; Guillot J; Kallel K; Jouvion G; Brisebard E; Billaud E; Jullien V; Botterel F; Dannaoui E
    J Fungi (Basel); 2021 Nov; 7(12):. PubMed ID: 34946994
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aneuploidy Formation in the Filamentous Fungus Aspergillus flavus in Response to Azole Stress.
    Barda O; Sadhasivam S; Gong D; Doron-Faigenboim A; Zakin V; Drott MT; Sionov E
    Microbiol Spectr; 2023 Aug; 11(4):e0433922. PubMed ID: 37358460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotypic and Genotypic Evaluation of Azole Resistance in Aspergillus fumigatus Isolates from Clinical and Environmental Specimens].
    Doğan Ö; Gülmez D; Arıkan Akdağlı S
    Mikrobiyol Bul; 2020 Apr; 54(2):291-305. PubMed ID: 32723284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
    Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Implication of Azole Persistence in the Treatment Failure of Two Haematological Patients Infected with
    Peláez-García de la Rasilla T; Mato-López Á; Pablos-Puertas CE; González-Huerta AJ; Gómez-López A; Mellado E; Amich J
    J Fungi (Basel); 2023 Jul; 9(8):. PubMed ID: 37623576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
    Garcia-Rubio R; Alcazar-Fuoli L; Monteiro MC; Monzon S; Cuesta I; Pelaez T; Mellado E
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azole and fungicide resistance in clinical and environmental Aspergillus fumigatus isolates.
    Meneau I; Sanglard D
    Med Mycol; 2005 May; 43 Suppl 1():S307-11. PubMed ID: 16110825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.
    Alcazar-Fuoli L; Buitrago M; Gomez-Lopez A; Mellado E
    Virulence; 2015; 6(4):376-84. PubMed ID: 26065322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine.
    Dos Reis TF; Horta MAC; Colabardini AC; Fernandes CM; Silva LP; Bastos RW; Fonseca MVL; Wang F; Martins C; Rodrigues ML; Silva Pereira C; Del Poeta M; Wong KH; Goldman GH
    mBio; 2021 Aug; 12(4):e0145821. PubMed ID: 34372704
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Colley T; Sehra G; Chowdhary A; Alanio A; Kelly SL; Kizawa Y; Armstrong-James D; Fisher MC; Warrilow AGS; Parker JE; Kelly DE; Kimura G; Nishimoto Y; Sunose M; Onions S; Crepin D; Lagasse F; Crittall M; Shannon J; McConville M; King-Underwood J; Naylor A; Bretagne S; Murray J; Ito K; Strong P; Rapeport G
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439966
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
    Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Powerful and Real-Time Quantification of Antifungal Efficacy against Triazole-Resistant and -Susceptible Aspergillus fumigatus Infections in Galleria mellonella by Longitudinal Bioluminescence Imaging.
    Vanhoffelen E; Michiels L; Brock M; Lagrou K; Reséndiz-Sharpe A; Vande Velde G
    Microbiol Spectr; 2023 Aug; 11(4):e0082523. PubMed ID: 37466453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of azole resistant-
    Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
    J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Jemel S; Raveloarisaona Y; Bidaud AL; Djenontin E; Kallel A; Guillot J; Kallel K; Botterel F; Dannaoui E
    Front Cell Infect Microbiol; 2022; 12():1038342. PubMed ID: 36733850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
    Chowdhary A; Sharma C; Hagen F; Meis JF
    Future Microbiol; 2014; 9(5):697-711. PubMed ID: 24957095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical epidemiology of pulmonary aspergillosis in hospitalized patients and contribution of Cyp51A, Yap1, and Cdr1B mutations to voriconazole resistance in etiologic Aspergillus species.
    Salehi Z; Sharifynia S; Jamzivar F; Shams-Ghahfarokhi M; Poorabdollah M; Abtahian Z; Nasiri N; Marjani M; Moniri A; Salehi M; Tabarsi P; Razzaghi-Abyaneh M
    Eur J Clin Microbiol Infect Dis; 2023 Jul; 42(7):853-864. PubMed ID: 37142789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.